Michael Robbins, DO
Interventional Pain Medicine · Hartford, CTNPI 1477665420
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Spinal Simplicity, LLC at 32.4% of the total. Reporting peaked in 2022 at $1,504 and has fallen 93.0% since, to $106 in 2025.
Across 141 payments — averaging $32.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$1K
- Relievant Medsystems, Inc.$567
- Boston Scientific$425
- Collegium Pharmaceutical, Inc.$239
- Medtronic$201
- Arbor Pharmaceuticals, Inc.$139
- plus $1K from 26 others
What the payments were for
- Travel & lodging$1,81940%
- Food & beverage$2,61158%
- Education$1042%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 12 | $1,469 |
| Relievant Medsystems, Inc. | 4 | $567 |
| Boston Scientific | 7 | $425 |
| Collegium Pharmaceutical, Inc. | 31 | $239 |
| Medtronic(2 entities) | 4 | $201 |
| Arbor Pharmaceuticals, Inc. | 8 | $139 |
| MDD US Operations, LLC | 6 | $129 |
| Scilex Pharmaceuticals Inc. | 8 | $121 |
| Nevro Corp. | 4 | $115 |
| Abbott | 7 | $115 |
| Saluda Medical Americas, Inc. | 2 | $103 |
| Merz North America, Inc. | 4 | $89 |
| Daiichi Sankyo Inc. | 4 | $83 |
| Vertiflex, Inc. | 3 | $82 |
| Sentynl Therapeutics, Inc. | 5 | $80 |
| Amgen(2 entities) | 4 | $69 |
| Pfizer | 4 | $58 |
| Vertos Medical, Inc. | 1 | $55 |
| Lilly USA, LLC | 3 | $51 |
| Kaleo, Inc. | 2 | $45 |
| Vertical Pharmaceuticals, LLC | 2 | $38 |
| AstraZeneca | 3 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Novartis | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Shionogi Inc | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$1,287
- Intracept$1,020
- INTELLIS ADAPTIVESTIM$141
- SUPERION$107
How this compares
Too few interventional pain medicine providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 11 | $70 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Hartford
- Michael GrilleHartford$10K
- Richard LucarelliVernon$71K
- Mohan VodapallyHamden$26K
- Mark ThimineurDerby$17K
- Robert BoolbolFarmington$15K
- Shyam DesaiFairfield$14K
- Jonathan KostWest Hartford$10K
- Pardeep SoodTrumbull$8K
- Vincent CarlesiDanbury$8K
- Dwight LighamNew Haven$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.